Concerns have been raised about the effectiveness of US software firm Palantir's technology in improving operational efficiency across a significant number of hospital trusts in England. While some trusts have reported positive results since adopting the company's Federated Data Platform (FDP), data suggests that many others have seen no improvement – or even a decline – in key performance metrics.
Palantir, which has previously worked on defence and intelligence projects, secured a £480 million contract with NHS England in November 2023 for its FDP. The platform aims to centralise and streamline access to patient data, ultimately improving patient care, optimising supply chains, and reducing the substantial waiting lists that have plagued the NHS.
The mixed picture emerging from the early implementation raises questions about the widespread effectiveness of the technology in its current application across the diverse NHS landscape. While some trusts have reported efficiency gains, such as faster patient discharge or better bed management, these appear to be exceptions rather than a consistent trend.
As the NHS continues to face unprecedented challenges, including a record waiting list of over 7.5 million people for elective care in England (as of December 2023), it's essential to scrutinise any technology promising significant improvements. The disparity in outcomes highlights the complexity of integrating advanced data platforms into a vast and intricate healthcare system like the NHS.
The long-term objective of the FDP is to provide a unified view of data, enabling clinicians and managers to make more informed decisions. However, current data suggests this vision is not yet uniformly realised. Further evaluation will be necessary to understand the full scope of the FDP's impact and ensure value for money from public funds.
The performance of key technological partnerships, such as that with Palantir, will be closely watched as the NHS continues its digital transformation journey. Addressing the persistent pressures on healthcare services requires more than just multi-million-pound investments; it demands robust evaluation and effective implementation of technologies like the FDP.